Stocks making the biggest moves premarket: Twitter, Affirm, Robinhood and more

Stocks making the biggest moves premarket: Twitter, Affirm, Robinhood and more


Check out the companies making headlines before the bell:

Twitter (TWTR) – Twitter tumbled 14.6% in premarket trading after Elon Musk tweeted that his deal to buy the company was “temporarily” on hold, as he awaits details on the number of fake and spam accounts on the platform.

Affirm Holdings (AFRM) – Affirm reported a quarterly loss of 19 cents per share, smaller than the 51 cent loss that analysts were anticipating, with the fintech company’s revenue beating forecasts. Affirm also raised its full-year revenue outlook and announced the extension of its ongoing partnership with e-commerce platform operator Shopify. The stock rocketed 33.8% higher in the premarket.

Robinhood Markets (HOOD) – Robinhood soared 22.4% in premarket trading after Sam Bankman-Fried – who founded cryptocurrency exchange FTX – revealed a 7.6% stake in a regulatory filing. The purchase makes him the third largest shareholder in the trading platform company.

Toast (TOST) – Toast added 3.2% in the premarket after the restaurant-focused technology platform company reported a smaller than expected quarterly loss as well as revenue that beat Street forecasts. It also raised its full-year revenue forecast, as more restaurants adopt Toast’s technology.

MicroStrategy (MSTR) – MicroStrategy rallied 13.9% in premarket action in what’s been a volatile week for the business analytics company. MicroStrategy, which has extensive bitcoin holdings, saw its stock fall more than 25% on both Monday and Wednesday before rising yesterday.

Roper Technologies (ROP) – The software and engineered products company is near a deal to sell its process-technology unit to private equity firm Clayton Dubilier & Rice for about $3 billion, according to people familiar with the matter who spoke to Bloomberg.

The Honest Company (HNST) – The Honest Company’s stock rose 3.1% in premarket trading after it reaffirmed its full-year revenue outlook. The personal care and household products company also reported a quarterly loss and revenue numbers that were both in line with Wall Street forecasts.

Duolingo (DUOL) – The language software provider’s stock surged 15.3% in the premarket after it reported a narrower quarterly loss and better than expected revenue. Duolingo said active user numbers are at an all-time high, and it issued upbeat current quarter revenue guidance.

Figs (FIGS) – The health care apparel company saw its stock plummet 25.2% in premarket trading after it missed estimates with its latest quarterly results and issued weaker than expected full-year guidance.

Poshmark (POSH) – The online apparel marketplace operator reported a loss of 18 cents per share, 4 cents smaller than Wall Street had anticipated, with revenue also beating estimates. That helped send its stock up 2.1% in premarket action, even though Poshmark issued a weaker than expected current quarter revenue forecast.



Source

Business class+? Delta says segmentation is coming to high-end cabins
Business

Business class+? Delta says segmentation is coming to high-end cabins

Nurphoto | Nurphoto | Getty Images Delta Air Lines is studying new types of airplane tickets — this time in the premium cabins at the front of the plane. Airlines spent years slicing up their coach cabins, from extra legroom seats to bare-bones basic economy fares that don’t allow changes or include a seat assignment. […]

Read More
Trump’s tariffs on Brazil could make your coffee even more expensive
Business

Trump’s tariffs on Brazil could make your coffee even more expensive

President Donald Trump’s proposed 50% tariff on Brazilian imports is bad news for coffee drinkers. Brazil, the largest U.S. supplier of green coffee beans, accounts for about a third of the country’s total supply, according to data from the U.S. Department of Agriculture. Coffee beans need to grow in a warm, tropical climate, making Hawaii […]

Read More
Space startup Varda raises 7 million in funding to make drugs in orbit
Business

Space startup Varda raises $187 million in funding to make drugs in orbit

Pavlo Gonchar | Lightrocket | Getty Images Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space. The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. […]

Read More